While Sasami has always slipped easily between genres, her latest career move surprised even her most ardent fans — but her pivot to pop is just the next stop on a trajectory that’s been in ...
The phase III Launch-HTN study hit its primary endpoint in reducing systolic blood pressure and the phase II Advance-HTN study also met its primary endpoint of a clinically meaningful reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback